(Q36379126)

13 August 2017

1 reference

title

Drug interactions in epilepsy. (English)

1 reference

13 August 2017

Brodie MJ

1

1 reference

13 August 2017

publication date

1 January 1992

1 reference

13 August 2017

1 reference

13 August 2017

volume

33 Suppl 1

1 reference

13 August 2017

page(s)

S13-22

1 reference

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Established anticonvulsants and treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Management of epilepsy during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

New and potential anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Interactions of valproic acid with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Factors relating to dramatic response to clobazam therapy in refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Interaction between vigabatrin and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Epidemiology, classification, natural history, and genetics of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Lithium-carbamazepine neurotoxicity and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Mechanisms of antiepileptic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

Carbamazepine-10,11-epoxide in epilepsy. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1992.TB05896.X

10.1111/J.1528-1157.1992.TB05896.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference